These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 12354487

  • 21. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S.
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [Abstract] [Full Text] [Related]

  • 22. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ, Taylor R, Wilcken N, Fiorica J, Boyages J.
    Breast J; 2005 Oct; 11(6):410-5. PubMed ID: 16297085
    [Abstract] [Full Text] [Related]

  • 23. HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped.
    Holmberg L, Anderson H, HABITS steering and data monitoring committees.
    Lancet; 2004 Feb 07; 363(9407):453-5. PubMed ID: 14962527
    [Abstract] [Full Text] [Related]

  • 24. Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1996 Nov 02; 348(9036):1189-96. PubMed ID: 8898035
    [Abstract] [Full Text] [Related]

  • 25. Breast cancer and HRT--what are the data?
    Bieber EJ, Barnes RB.
    Int J Fertil Womens Med; 2001 Nov 02; 46(2):73-8. PubMed ID: 11374658
    [Abstract] [Full Text] [Related]

  • 26. Hormone-replacement therapy: current thinking.
    Lobo RA.
    Nat Rev Endocrinol; 2017 Apr 02; 13(4):220-231. PubMed ID: 27716751
    [Abstract] [Full Text] [Related]

  • 27. Has the impact of hormone replacement therapy on health-related quality of life been undervalued?
    Tosteson AN, Gabriel SE, Kneeland TS, Moncur MM, Manganiello PD, Schiff I, Ettinger B, Melton LJ.
    J Womens Health Gend Based Med; 2000 Mar 02; 9(2):119-30. PubMed ID: 10746515
    [Abstract] [Full Text] [Related]

  • 28. Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries.
    Zbuk K, Anand SS.
    J Epidemiol Community Health; 2012 Jan 02; 66(1):1-7. PubMed ID: 21875869
    [Abstract] [Full Text] [Related]

  • 29. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct 11; 350(9084):1047-59. PubMed ID: 10213546
    [Abstract] [Full Text] [Related]

  • 30. The HRT misuse and osteoporosis epidemic: a possible future scenario.
    Gambacciani M, Ciaponi M, Genazzani AR.
    Climacteric; 2007 Aug 11; 10(4):273-5. PubMed ID: 17653953
    [Abstract] [Full Text] [Related]

  • 31. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK, Chick P.
    Med J Aust; 1992 Jan 20; 156(2):124-32. PubMed ID: 1736053
    [Abstract] [Full Text] [Related]

  • 32. Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.
    Bromley SE, de Vries CS, Thomas D, Farmer RD.
    Drug Saf; 2005 Jan 20; 28(6):473-93. PubMed ID: 15924502
    [Abstract] [Full Text] [Related]

  • 33. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M, Sands RH, McLaren M, Kirk G, Darko D.
    Fam Pract; 2000 Dec 20; 17(6):497-507. PubMed ID: 11120722
    [Abstract] [Full Text] [Related]

  • 34. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
    Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR.
    Gynecol Endocrinol; 2009 Dec 20; 25(12):807-15. PubMed ID: 19906000
    [Abstract] [Full Text] [Related]

  • 35. [Hormone replacement therapy in menopause and risk of breast cancer].
    Fournier A, Hill C, Clavel-Chapelon F.
    Bull Cancer; 2003 Oct 20; 90(10):821-31. PubMed ID: 14706912
    [Abstract] [Full Text] [Related]

  • 36. Hormone replacement therapy and the breast.
    Dixon JM.
    Surg Oncol; 2003 Dec 20; 12(4):251-63. PubMed ID: 14998565
    [Abstract] [Full Text] [Related]

  • 37. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ, Zuckerman IH, Lee E.
    J Womens Health (Larchmt); 2004 Nov 20; 13(9):986-92. PubMed ID: 15665655
    [Abstract] [Full Text] [Related]

  • 38. Hormone replacement therapy and risk of non-fatal stroke.
    Pedersen AT, Lidegaard O, Kreiner S, Ottesen B.
    Lancet; 1997 Nov 01; 350(9087):1277-83. PubMed ID: 9357407
    [Abstract] [Full Text] [Related]

  • 39. [Hormonal replacement therapy and breast cancer].
    This P.
    Rev Prat; 2005 Feb 28; 55(4):377-82. PubMed ID: 15828615
    [Abstract] [Full Text] [Related]

  • 40. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.
    Bakken K, Alsaker E, Eggen AE, Lund E.
    Int J Cancer; 2004 Oct 20; 112(1):130-4. PubMed ID: 15305384
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.